“…With occurrence in animals, plants and microorganisms [ 24 , 25 , 26 , 27 ], the bioprospection of glucosidase inhibitors in sustainable natural sources was once concentrated on macroalgae [ 28 , 29 , 30 ] but it is interesting to look for alternatives with cheaper cultivation and that require less area, such as microalgae, including cyanobacteria [ 31 , 32 , 33 , 34 , 35 , 36 , 37 ]. The possibility of associating the production of these inhibitors with other metabolites of biotechnological interest produced by cyanobacteria, such as antioxidants [ 38 ]; pigments [ 39 ], acids and polysaccharides of cosmetic and pharmacological interest [ 40 , 41 ] in addition to joint production with polyhydroxybutyrate (PHB) [ 42 , 43 ] and biofuels [ 44 , 45 , 46 ], while mitigating CO 2 [ 43 , 44 ], is yet another advantage of this bacterial phylum.…”